PT MERCK TBK +$0 +0% Saturday 00:07
1D 1W 1M 3M 1Y 5Y
0 % Dividend Yield
18.54% Profit Margin
Profitable 62.5M Revenue
11.59M Net Income
This list is based on the watchlists of people on Stock Events who follow PMKIF. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Kimia Farma Tbk PT
KAEF.JK
Mkt Cap 5.75T
Kalbe Farma operates in the pharmaceutical sector in Indonesia, directly competing with Merck Tbk PT in terms of product offerings and market share. Kalbe Farma Tbk PT
KLBF.JK
Mkt Cap 95.29T
Kimia Farma is another major player in the Indonesian pharmaceutical industry, offering a range of products that compete with Merck Tbk PT's portfolio. Organon Pharma Indonesia Tbk PT
SCPI.JK
Mkt Cap 0
Indofarma Tbk competes in the same space, providing pharmaceuticals and health products that rival Merck Tbk PT's offerings. Pyridam Farma Tbk PT
PYFA.JK
Mkt Cap 462.84B
Phapros Tbk operates in the pharmaceutical sector, offering products that compete with Merck Tbk PT in the Indonesian market. Darya-Varia Laboratoria Tbk PT
DVLA.JK
Mkt Cap 2.5T
Darya-Varia Laboratoria Tbk is involved in manufacturing and marketing pharmaceutical products, competing with Merck Tbk PT in terms of product range and market presence. Millennium Pharmacon International Tbk PT
SDPC.JK
Mkt Cap 315.95B
Indo Farma Tbk is a competitor in the pharmaceutical industry, offering a range of products that compete with those of Merck Tbk PT. Tempo Scan Pacific Tbk PT
TSPC.JK
Mkt Cap 6.29T
Tempo Scan Pacific Tbk competes with Merck Tbk PT by offering a diverse range of pharmaceutical and healthcare products in the Indonesian market. Bank Mayapada Internasional Tbk PT
MAYA.JK
Mkt Cap 6.09T
Mayora Indah Tbk, though primarily focused on consumer goods, competes in the health segment with nutritional and health-related products. Unilever Indonesia Tbk PT
UNVR.JK
Mkt Cap 181.98T
Unilever Indonesia Tbk, with its wide range of consumer goods, indirectly competes with Merck Tbk PT in the health and wellness sector through its health-related products.
PT Merck Tbk manufactures and sells pharmaceutical products in Indonesia. It operates through three segments: Biopharma, Consumer Health, and Others. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in discovering, developing, manufacturing, and marketing pharmaceutical and biological prescription medicines to treat colorectal cancer, head and neck cancer, multiple sclerosis, infertility, growth hormone disorders, and diabetes, as well as thyroid disorders comprising hyperthyroidism and hypothyroidism. In addition, it leases and manages properties. The company was formerly known as PT Merck Indonesia Tbk and changed its name to PT Merck Tbk in June 2002. The company was founded in 1970 and is headquartered in East Jakarta, Indonesia. PT Merck Tbk is a subsidiary of Merck Holding GmbH.
Show more...
FAQ What is PT MERCK TBK stock ticker?▼ Depending on the exchange, the stock ticker may vary. For instance, on exchange PT MERCK TBK stocks are traded under the ticker PMKIF.
What is PT MERCK TBK revenue for the last year?▼ PT MERCK TBK revenue for the last year amounts to 62.5M USD.
What is PT MERCK TBK net income for the last year?▼ PMKIF net income for the last year is 11.59M USD.
Does PT MERCK TBK pay dividends?▼ Yes, PMKIF dividends are paid annual. The last dividend per share was 0.02 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does PT MERCK TBK have?▼ As of April 03, 2026, the company has 393 employees.
In which sector is PT MERCK TBK located?▼ PT MERCK TBK operates in the Healthcare sector.
When did PT MERCK TBK complete a stock split?▼ The last stock split for PT MERCK TBK was on October 14, 2016 with a ratio of 20:1.
Where is PT MERCK TBK headquartered?▼ PT MERCK TBK is headquartered in Jakarta Timur, Indonesia.